z-logo
Premium
Serum Opsonins and Chemotactins in Neutropenic Oncology Patients
Author(s) -
Stempel D. A.,
Eden O. B.,
Gilkerson E.,
Berberich F. R.
Publication year - 1979
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.1979.19379204222.x
Subject(s) - opsonin , medicine , neutropenia , chemotherapy , immunology , antibody , oncology
Serum opsonins and chemotactins, C 3 and C 5 , were studied in neutropenic oncology patients. Our data indicate that these individuals possess normal serum chemotactins and adequate opsonin activity regardless of disease status or prior chemotherapy. Their sera should therefore support function of transfused granulocytes.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here